Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024
Rhea-AI Summary
Sensus Healthcare (Nasdaq: SRTS), a medical device company specializing in non-invasive treatments for oncological and non-oncological conditions, has announced its upcoming second quarter 2024 financial results and business update conference call. The call is scheduled for Thursday, August 8, 2024, at 4:30 p.m. Eastern time.
Key points:
- Management will discuss Q2 2024 financial results
- A business update and discussion on recent and upcoming milestones will be provided
- Participants can pre-register for the call or dial in directly
- A webcast will be available on the company's Investor Relations website
- A telephone replay will be accessible until September 8th
Positive
- Sensus Healthcare is maintaining transparency by hosting a quarterly financial results call
- The company will provide updates on recent and upcoming milestones, indicating potential growth opportunities
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, SRTS declined 1.10%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
BOCA RATON, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may access the conference call by dialing, 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until September 8th, and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International). At the system prompt, dial the replay code – 2699495 – followed by the # sign. Playback will automatically begin. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com
# # #
FAQ
When is Sensus Healthcare (SRTS) releasing its Q2 2024 financial results?
How can investors participate in Sensus Healthcare's (SRTS) Q2 2024 earnings call?
Will there be a replay available for Sensus Healthcare's (SRTS) Q2 2024 earnings call?
What topics will be covered in Sensus Healthcare's (SRTS) Q2 2024 conference call?
